- Randomized clinical trial of laparoscopic gastric bypass versus laparoscopic duodenal switch for superobesityT T Søvik
Departments of Gastrointestinal Surgery, Oslo University Hospital Aker, Oslo, Norway
Br J Surg 97:160-6. 2010..A randomized trial was conducted to evaluate perioperative (30-day) safety and 1-year results...
- [Type 2 diabetes and metabolic syndrome before and after gastric bypass]Torgeir T Søvik
Senter for sykelig overvekt og Gastroenterologisk kirurgisk avdeling, Oslo universitetssykehus, Aker 0514 Oslo, Norway
Tidsskr Nor Laegeforen 130:1347-50. 2010..Overweight and obesity are associated with an increased risk of acquiring type 2 diabetes and metabolic syndrome. We have assessed the prevalence of these conditions before and after gastric bypass surgery for morbid obesity...
- Weight loss, cardiovascular risk factors, and quality of life after gastric bypass and duodenal switch: a randomized trialTorgeir T Søvik
Oslo University Hospital Aker, University of Oslo, Norway
Ann Intern Med 155:281-91. 2011..Gastric bypass and duodenal switch are currently performed bariatric surgical procedures. Uncontrolled studies suggest that duodenal switch induces greater weight loss than gastric bypass...